Ling Duan

492 total citations
35 papers, 355 citations indexed

About

Ling Duan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ling Duan has authored 35 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Ling Duan's work include CNS Lymphoma Diagnosis and Treatment (5 papers), Virus-based gene therapy research (4 papers) and Ferroptosis and cancer prognosis (4 papers). Ling Duan is often cited by papers focused on CNS Lymphoma Diagnosis and Treatment (5 papers), Virus-based gene therapy research (4 papers) and Ferroptosis and cancer prognosis (4 papers). Ling Duan collaborates with scholars based in China, United States and Australia. Ling Duan's co-authors include Daqing Li, Bert W. O’Malley, Duane A. Sewell, James W. Rocco, William H. Liggett, David Sidransky, John K. Saunders, Savio L.C. Woo, Ken-ichiro Kosai and Mary R. Schwartz and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and Life Sciences.

In The Last Decade

Ling Duan

30 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Duan China 10 199 122 112 57 46 35 355
Esha Sachdev United States 7 144 0.7× 166 1.4× 100 0.9× 40 0.7× 36 0.8× 9 382
Sylvain Ferrandon United States 12 265 1.3× 164 1.3× 51 0.5× 72 1.3× 38 0.8× 13 464
Tatiana Cajuso Finland 9 331 1.7× 134 1.1× 61 0.5× 47 0.8× 23 0.5× 10 489
Buyun Ma China 14 265 1.3× 130 1.1× 116 1.0× 21 0.4× 45 1.0× 25 518
Anne Dumay France 10 326 1.6× 225 1.8× 80 0.7× 53 0.9× 39 0.8× 17 559
Linhua Ji China 13 296 1.5× 88 0.7× 108 1.0× 53 0.9× 52 1.1× 35 500
Ryan J. Rebernick United States 8 245 1.2× 74 0.6× 35 0.3× 55 1.0× 134 2.9× 16 452
Yingfei Li China 12 247 1.2× 103 0.8× 43 0.4× 32 0.6× 44 1.0× 21 408
Alina Janney United Kingdom 4 228 1.1× 110 0.9× 33 0.3× 19 0.3× 53 1.2× 4 359
Yoshinori Morimoto Japan 10 166 0.8× 111 0.9× 51 0.5× 54 0.9× 69 1.5× 22 413

Countries citing papers authored by Ling Duan

Since Specialization
Citations

This map shows the geographic impact of Ling Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Duan more than expected).

Fields of papers citing papers by Ling Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Duan. The network helps show where Ling Duan may publish in the future.

Co-authorship network of co-authors of Ling Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Duan. A scholar is included among the top collaborators of Ling Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Duan. Ling Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Wenjun, Jing Li, Guoying Zhang, et al.. (2025). The association between stress hyperglycemia and poor outcome in critically ill children is modulated by hyperlactatemia. Frontiers in Endocrinology. 16. 1518746–1518746.
3.
4.
Duan, Ling, et al.. (2024). Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma. Journal of Neuro-Oncology. 168(2). 283–298. 4 indexed citations
5.
Yang, Ge, et al.. (2024). GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration. Cancer Immunology Immunotherapy. 73(7). 131–131. 7 indexed citations
6.
7.
8.
Qiu, Lijuan, et al.. (2023). Hepatic adenoma in a 7-year-old girl: a case report and literature review. BMC Pediatrics. 23(1). 420–420. 2 indexed citations
9.
10.
Zhou, Yi, Ling Duan, Yan Zeng, et al.. (2023). The panda-derived Lactiplantibacillus plantarum BSG201683 improves LPS-induced intestinal inflammation and epithelial barrier disruption in vitro. BMC Microbiology. 23(1). 249–249. 6 indexed citations
11.
Duan, Ling, et al.. (2022). Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma. Technology in Cancer Research & Treatment. 21. 4 indexed citations
12.
Yao, Qian, et al.. (2022). Combination of levofloxacin and cisplatin enhances anticancer efficacy via co-regulation of eight cancer-associated genes. Discover Oncology. 13(1). 76–76. 9 indexed citations
13.
Duan, Ling, et al.. (2022). Identification of Autophagy-Related LncRNA to Predict the Prognosis of Colorectal Cancer. Frontiers in Genetics. 13. 906900–906900. 8 indexed citations
14.
Zhou, Yi, Ling Duan, Yan Zeng, et al.. (2021). The Panda-Derived Lactobacillus plantarum G201683 Alleviates the Inflammatory Response in DSS-Induced Panda Microbiota-Associated Mice. Frontiers in Immunology. 12. 747045–747045. 9 indexed citations
15.
Zhou, Yi, Xueqin Ni, Ling Duan, et al.. (2020). Lactobacillus plantarum BSGP201683 Improves the Intestinal Barrier of Giant Panda Microbiota-Associated Mouse Infected by Enterotoxigenic Escherichia coli K88. Probiotics and Antimicrobial Proteins. 13(3). 664–676. 12 indexed citations
16.
Xu, Lei, Hao Li, Wenjuan Zeng, et al.. (2019). Interference in the indirect antiglobulin test and direct antiglobulin test from rheumatoid factor. Journal of International Medical Research. 48(3). 1219691938–1219691938. 4 indexed citations
17.
Duan, Ling, et al.. (2017). Treatment mechanism of matrine in combination with irinotecan for colon cancer. Oncology Letters. 14(2). 2300–2304. 19 indexed citations
18.
Kolb, Todd M., Ling Duan, & Myrtle A. Davis. (2005). Tsc2 Expression Increases the Susceptibility of Renal Tumor Cells to Apoptosis. Toxicological Sciences. 88(2). 331–339. 10 indexed citations
19.
O’Malley, Bert W., et al.. (1999). Limitations of adenovirus‐mediated interleukin‐2 gene therapy for oral cancer. The Laryngoscope. 109(3). 389–395. 19 indexed citations
20.
Sewell, Duane A., Daqing Li, Ling Duan, Mary R. Schwartz, & Bert W. O’Malley. (1997). Optimizing Suicide Gene Therapy for Head and Neck Cancer. The Laryngoscope. 107(11). 1490–1495. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esha Sachdev Breakdown of academic impact, for papers by Sylvain Ferrandon Breakdown of academic impact, for papers by Tatiana Cajuso Breakdown of academic impact, for papers by Buyun Ma Breakdown of academic impact, for papers by Anne Dumay Breakdown of academic impact, for papers by Linhua Ji Breakdown of academic impact, for papers by Ryan J. Rebernick Breakdown of academic impact, for papers by Yingfei Li Breakdown of academic impact, for papers by Alina Janney Breakdown of academic impact, for papers by Yoshinori Morimoto
Rankless by CCL
2026